Actualités

The average American household spent $78,535 in 2024, according to the latest Bureau of Labor Statistics Consumer Expenditure Survey. Round that to $80,000, and you have a useful starting point for the retirement paycheck many households may need to replace. Gross salary can overstate the target because it includes payroll taxes, retirement contributions, and expenses ... How A 2.5% Yield Can Turn Into A Retirement Paycheck That Keeps Growing

Turning $500,000 into $100,000 of annual income requires a 20% yield, and no durable, diversified income portfolio should be built around that assumption. Anyone quoting a number that high is usually taking on extreme risk, relying on leverage, or handing back some of your own capital. The dividend-growth formula solves a different equation. It accepts ... The Dividend Growth Formula That Turns $500,000 Into a Six-Figure Income Stream

A 2% yield looks weak next to a 10% high-yield fund, at least on day one. Most income screens sort by current yield in descending order, which means companies with the strongest dividend-growth records can sit near the bottom of the list. That ranking is the trap. Current yield is a snapshot. It tells you ... Why Today’s Dividend Yield May Be The Least Important Number In Your Portfolio

A 12% yield looks unbeatable on day one. A retiree who wants $60,000 a year needs only about $500,000 at that yield, compared with roughly $1.7 million at a 3.5% yield. But retirement income is not a one-year problem. The better question is which income stream can hold up after inflation, market cycles, and years ... The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later

Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at the memory chip trade — particularly the intraday performances of Micron Technology (MU), SK Hynix (000660.KS), and Samsung (005930.KS) — as these three big names have seemingly dragged the sector into a bear market.

Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at the memory chip trade — particularly the intraday performances of Micron Technology (MU), SK Hynix (000660.KS), and Samsung (005930.KS) — as these three big names have seemingly dragged the sector into a bear market.

Johnson & Johnson (JNJ) has become a talking point after presenting new IMAAVY data for generalized myasthenia gravis at the European Academy of Neurology Congress, giving investors fresh information on its autoimmune portfolio. See our latest analysis for Johnson & Johnson. The IMAAVY update lands at a time when Johnson & Johnson shares have strong momentum, with an 11.41% 30 day share price return and a 25.07% year to date share price return, alongside a 71.19% 1 year total shareholder...

Today, there has been large and unusual put option activity in Johnson & Johnson (JNJ) after the stock's recent rise. The puts are out-of-the-money (OTM), implying that some investors believe JNJ could tank.

Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off cash, growing earnings, and reaffirming guidance. For retail investors scanning for value, the sub-$30 shelf in healthcare currently offers exposure to a pending strategic ... 3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now

Liquidia has surged 129.7% so far in 2026 as Yutrepia gains traction, driving strong sales, profitability and higher earnings estimates.

Protagonist shares rise as rusfertide nears an FDA decision and Icotyde adds milestone payments, royalties and broader pipeline momentum.

Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.

US markets are set for a mixed open on Tuesday, with technology stocks expected to come under pressure after Samsung delivered record quarterly profits that still failed to satisfy investors, raising fresh questions about AI valuations. Nasdaq futures were down 1.1% ahead of the opening bell,...

Replacing $1,500 a month in portfolio income looks simple until yield enters the equation. At a 3.5% yield, you need roughly $514,000 invested. At 6%, the target falls to $300,000. At 10%, it drops to $180,000. Those numbers seem to reward the highest-yielding portfolio, but the real question is what you may have to give ... The $1,500-A-Month Portfolio: Conservative, Moderate, And High-Yield Paths Compared

7.47am: Shell gives pre-results update Shell says stronger trading in its integrated gas business and improved refining margins should support second-quarter performance, although production has been hit by disruption to output from Qatar following the Iran war. Ahead of second-quarter...

Before the share price caught on, the drugmaker was dealing with a problem most companies only dream of, and it was the clearest sign a surge was building.

A retiree who starts with a 10% dividend yield can collect far more income on day one than someone earning 3.5%. Twenty years later, the tables may have turned. One income stream stayed flat while inflation chipped away at its buying power. The other kept growing year after year until it was paying dramatically more. ... Double Your Retirement Income in a Decade. Here’s How.

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, are worth a look.

The personal saving rate was 3.0% in May 2026, while average annual household expenditures reached $78,535 in the 2024 Consumer Expenditure Survey. That gap helps explain why the income-ladder question keeps surfacing: what does it actually take to manufacture a paycheck from a portfolio when wages alone fall short? The math is unforgiving but simple. ... The Income Ladder: What It Takes To Go From $250 To $5,000 A Month

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.

Johnson & Johnson stock is Monday's IBD Stock Of The Day. The medical bellwether will report its June-quarter earnings next week.

While investors fixate on slowing elective surgeries, a powerful, non-obvious growth engine is accelerating inside the company's U.S. business.

JNJ's Q2 MedTech results will test whether cardiovascular, surgery and vision strength can offset ongoing China VBP headwinds and sustain growth.

ABBV's Q2 spotlight is on Skyrizi and Rinvoq as rising immunology sales aim to offset Humira's decline ahead of July 31 earnings.

Three under-the-radar dividend stocks with solid returns, low debt and room to grow.

A retiree with $500,000 can buy a high-yield income fund showing a 12% distribution rate today and collect $60,000 in the first year if the payout holds. That same $500,000 spread across quality dividend growers paying 3.5% generates just $17,500 in year one. The bigger check feels smart initially, but the math can turn against ... Why A Low-Yield Dividend Portfolio Could Pay More Than A High-Yield Portfolio In Retirement

These three healthcare stocks provide stability, relatively high dividend yields, and consistent growth.

US stocks are predicted to see a mixed start on Monday, with investors rotating back into technology shares after a softer-than-expected jobs report last week eased concerns that the Federal Reserve could raise interest rates again. Nasdaq futures were 1.1% higher ahead of the first trading...

8.39am: Airlines and pubs in good mood Shares in easyJet have flown almost 10% higher to 610p but are still well below the 690p potential offer price. Sector peer Jet2 is up 3.8% too, while long-haul peer IAG has risen 2.1%. The FTSE 100 and FTSE 250 are both on the front foot, up...

Investors continued to pump money into select companies backed by business developments rather than broad market trends.